{'fraction_non_alphanumeric': 0.021377672209026127, 'fraction_numerical': 0.0035629453681710215, 'mean_word_length': 5.798387096774194, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[A complex evaluation of the efficacy of aldecin in treating bronchial asthma patients].

AIM
Study of efficiency of inhalation glucocorticosteroid Aldecine.


MATERIALS AND METHODS
A 4-week trial of 30 patients with bronchial asthma. Treatment results were evaluated by clinical symptoms, demand of inhalation sympathomimetics, external respiration, viscosity and elasticity of bronchial secretion, concentrations of hydrocortisone and thyroid hormones.


RESULTS
Aldecine produced a good clinical effect, improved external respiration, allowed to reduce doses of inhalation beta-adrenomimetics. No deterioration of either bronchial secretion rheology or inhibition of adrenal and thyroid function was seen. Candidiasis was clinically negligible.


CONCLUSION
Aldecine proved highly effective and tolerable in patients with bronchial asthma.